These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34894388)

  • 21. Photodynamic therapy: current status and future directions.
    Benov L
    Med Princ Pract; 2015; 24 Suppl 1(Suppl 1):14-28. PubMed ID: 24820409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The photobiology of photodynamic therapy: cellular targets and mechanisms.
    Oleinick NL; Evans HH
    Radiat Res; 1998 Nov; 150(5 Suppl):S146-56. PubMed ID: 9806617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive Reductive Species Participating Photodynamic Therapy for Cancer Treatment.
    Peng J; Feng F
    Chemistry; 2024 Jan; 30(1):e202302842. PubMed ID: 37750352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers.
    Piette J; Volanti C; Vantieghem A; Matroule JY; Habraken Y; Agostinis P
    Biochem Pharmacol; 2003 Oct; 66(8):1651-9. PubMed ID: 14555246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy: oncologic horizons.
    Allison RR
    Future Oncol; 2014 Jan; 10(1):123-4. PubMed ID: 24328413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenalenone-photodynamic therapy induces apoptosis on human tumor cells mediated by caspase-8 and p38-MAPK activation.
    Salmerón ML; Quintana-Aguiar J; De La Rosa JV; López-Blanco F; Castrillo A; Gallardo G; Tabraue C
    Mol Carcinog; 2018 Nov; 57(11):1525-1539. PubMed ID: 30035337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.
    Barathan M; Mariappan V; Shankar EM; Abdullah BJ; Goh KL; Vadivelu J
    Cell Death Dis; 2013 Jun; 4(6):e697. PubMed ID: 23807226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activity of G-ROS and the predominant role of Type II reaction in the photodynamic therapy using 9-hydroxypheophorbide-α for HeLa cell lines.
    Ahn JC; Chung PS
    Gen Physiol Biophys; 2012 Sep; 31(3):343-50. PubMed ID: 23047947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy using pheophorbide and 670nm LEDs exhibits anti-cancer effects in-vitro in androgen dependent prostate cancer.
    Gheewala T; Skwor T; Munirathinam G
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():130-137. PubMed ID: 29102652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
    Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
    Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Review of Chemotherapy and Photodynamic Therapy for Lung Cancer Treatment.
    El-Hussein A; Manoto SL; Ombinda-Lemboumba S; Alrowaili ZA; Mthunzi-Kufa P
    Anticancer Agents Med Chem; 2021; 21(2):149-161. PubMed ID: 32242788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: Implications for photodynamic therapy.
    Ferino A; Rapozzi V; Xodo LE
    J Photochem Photobiol B; 2020 Jan; 202():111672. PubMed ID: 31778952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phototoxic effect of photodynamic therapy on lung cancer cells grown as a monolayer and three dimensional multicellular spheroids.
    Manoto SL; Houreld NN; Abrahamse H
    Lasers Surg Med; 2013 Mar; 45(3):186-94. PubMed ID: 23460580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some Natural Photosensitizers and Their Medicinal Properties for Use in Photodynamic Therapy.
    Kubrak TP; Kołodziej P; Sawicki J; Mazur A; Koziorowska K; Aebisher D
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35208984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical cancer cells (HeLa) response to photodynamic therapy using a zinc phthalocyanine photosensitizer.
    Hodgkinson N; Kruger CA; Mokwena M; Abrahamse H
    J Photochem Photobiol B; 2017 Dec; 177():32-38. PubMed ID: 29045918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy with TMPyP - Porphyrine induces mitotic catastrophe and microtubule disorganization in HeLa and G361 cells, a comprehensive view of the action of the photosensitizer.
    Cenklová V
    J Photochem Photobiol B; 2017 Aug; 173():522-537. PubMed ID: 28686960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review of Light Sources and Enhanced Targeting for Photodynamic Therapy.
    Xiang M; Zhou Q; Shi Z; Wang X; Li M; Jia Y; Li S; Yang F; Wang W; Chen T; Xu X; Sharma B; Nie Y; Xiao Q; Gao L
    Curr Med Chem; 2021; 28(31):6437-6457. PubMed ID: 33475053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy (PDT) resistance by PARP1 regulation on PDT-induced apoptosis with autophagy in head and neck cancer cells.
    Kim J; Lim W; Kim S; Jeon S; Hui Z; Ni K; Kim C; Im Y; Choi H; Kim O
    J Oral Pathol Med; 2014 Oct; 43(9):675-84. PubMed ID: 24931630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular response to hypericin-induced photodamage.
    Krammer B; Verwanger T
    Curr Med Chem; 2012; 19(6):793-8. PubMed ID: 22214453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy in dentistry.
    Konopka K; Goslinski T
    J Dent Res; 2007 Aug; 86(8):694-707. PubMed ID: 17652195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.